These experiments measure whether immune cells cause death of specified target cells. The target cells, comparison conditions and timing are part of the result.
A primary flow-cytometry method distinguished labeled target cells from immune effector cells and measured target death while characterizing the effector population. The study examined how timing and the effector-to-target ratio affected the assay. Degranulation markers provide a related functional readout, but they measure a step preceding cytolysis. Killing of a laboratory target does not establish recognition of every tumor cell or benefit in the person receiving a treatment.
Shares ELISpot secretion assays, Intracellular cytokine staining, Flow cytometry (immunophenotyping), Immune measurements and product evidence.
Shares T-cell receptor repertoire diversity and clonality, Peptide-HLA multimer staining, Immune measurements and product evidence.
Shares T-cell receptor repertoire diversity and clonality, Immune measurements and product evidence.
Shares Immunogenicity and clinical efficacy, Immune measurements and product evidence.
Shares Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Shares Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Shares Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Shares Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/